Prosecution Insights
Last updated: November 04, 2026
Application No. 18/920,304

WASTEWATER TREATMENT SYSTEM AND METHODS UTILIZING CHEMICAL PRE-TREATMENT AND FOAM FRACTIONATION

Non-Final OA §112§DOUBLEPATENT
Filed
Oct 18, 2024
Priority
Mar 29, 2019 — provisional 62/826,428 +3 more
Examiner
DRODGE, JOSEPH W
Art Unit
1773
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Aqua-Terra Consultants
OA Round
1 (Non-Final)
78%
Grant Probability
Favorable
1-2
OA Rounds
7m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allowance Rate
1598 granted / 2041 resolved
+13.3% vs TC avg
Strong +38% interview lift
Without
With
+37.9%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
40 currently pending
Career history
2085
Total Applications
across all art units

Statute-Specific Performance

§101
4.2%
-35.8% vs TC avg
§103
40.3%
+0.3% vs TC avg
§102
11.4%
-28.6% vs TC avg
§112
30.4%
-9.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 2041 resolved cases

Office Action

§112 §DOUBLEPATENT
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1, 2, 4-6, 8, 10, 11, 13 and 15-18 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-3, 5, 7-10 and 14 of U.S. Patent No. 11,518,699. Although the claims at issue are not identical, they are not patentably distinct from each other because the subject matter of the instant claims is emcompassed in the claims of patent ‘699, taken in combination, as outlined in the following side-by-side comparison of instant claims relative to claims of ‘699: Instant claim 1: A method, comprising: pretreating wastewater containing organic matters, the pretreating including adding one or more pretreatment chemicals to the wastewater to form a pretreated wastewater mixture (claim 1 of ‘699, “pretreating” clause); supplying the pretreated wastewater mixture into a foam fractionation system, whereby the pretreated wastewater mixture is separated into a foamate and an effluent within the foam fractionation system, wherein the foamate comprises foams on which at least a portion of the organic matters are adsorbed (claim 1 of ‘699, “supplying” clause); discharging the foamate from the foam fractionation system (claim 1 of ‘699, “discharging” clause, 1st portion) ; and adding chitosan to the foamate (claim 1 of ‘699, last clause). Instant claim 2. The method of claim 1, wherein the one or more pretreatment chemicals include ferric sulfate, and a pH adjuster suitable to adjust the pretreated wastewater mixture to a pH level at or below an isoelectric point of the wastewater (claim 1 of ‘699, “pretreating clause re “metal-based coagulant”, claim 3 re ferric sulfate, and pH adjuster, and claim 5 re isoelectric point). Instant claim 4. The method of claim 2, wherein the pH adjuster is selected from the group consisting of sodium bicarbonate, sodium hydroxide, and sulfuric acid (claim 3 of ‘699). Instant claim 5. The method of claim 2, wherein the one or more pretreatment chemicals further comprises an oxidant selected from hydrogen peroxide, peracetic acid, and a combination thereof (claims 2 and 3 of ‘699). Instant claim 6: “…wherein the supplying the pretreated wastewater mixture into the foam fractionation system includes pumping the pretreated wastewater mixture into the foam fractionation system proximate a first end of the foam fractionation system opposite a base of the foam fractionation system and operating the foam fractionation system counter-currently” (claims 7 and 8 of ‘699). Instant claim 8: “…further comprising: after the supplying, discharging the effluent, the discharging including flowing the effluent through at least one of a mesh screen or an ultraviolet treatment system to provide a refined effluent and discharging the refined effluent to a wastewater discharge” (claim 9 of ‘699). Instant claim 10: “… further comprising: after the discharging the foamate, dewatering the foamate, the dewatering the foamate including separating water from the foamate by gravity separation in a sludge tank” (claims 1 of ‘699, “discharging” clause, beginning “the dewatering” and claims 10 and 14 re “sludge tank”). Instant claim 11: “…wherein the dewatering the foamate further includes, before separating the water from the foamate by gravity separation, adding only the chitosan to the foamate and adjusting a pH of the foamate” (claim 1 of ‘699, “wherein” clause in entirety). Instant claim 13: A method, comprising: pretreating wastewater containing organic matters, the pretreating including adding one or more pretreatment chemicals to the wastewater first followed by adding sodium hydroxide to the wastewater to form a pretreated wastewater mixture (claim 1 of ‘699, “pretreating” clause); supplying the pretreated wastewater mixture into a foam fractionation system, whereby the pretreated wastewater mixture is separated into a foamate and an effluent within the foam fractionation system, wherein the foamate comprises foams on which at least a portion of the organic matters are adsorbed (claim 1 of ‘699, “supplying” clause); and, adding chitosan to the foamate (claim 1 of ‘699, last clause). 15. The method of claim 13, further comprising: after the supplying the pretreated wastewater mixture into the foam fractionation system, discharging the foamate to a sludge tank followed by the adding the chitosan to the foamate (paraphrased in claim 1 of ‘699, “discharging” clause). 16. The method of claim 15, further comprising: after the adding the chitosan to the foamate, dewatering the foamate in the sludge tank, including separating water from the foamate by gravity separation (paraphrased in claim 1 of ‘699, “discharging” clause). 17. The method of claim 13, wherein the adding the chitosan to the foamate includes adding only the chitosan and a pH adjuster to the foamate, the method further comprising (claim 1 of ‘699, “wherein” clause and claim 2): after the adding the chitosan, dewatering the foamate in a sludge tank by gravity separation (claim 1 of ‘699, “discharging” clause). 18. The method of claim 13, wherein the pretreating the wastewater further includes adding one or more of sulfuric acid, sodium bicarbonate, and hydrogen peroxide to the wastewater to form the pretreated wastewater mixture (claim 3 of ‘699). Claim Rejections - 35 USC § 112 Claims 1-20 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In each of independent claims 1 and 13, “organic matters” is ambiguous as to whether the term refers to more than one organic matter type or component, or the term is a mis-spelling of “organic matter”. In claim 5, “comprises” (singular) is inconsistent with “chemicals” (plural) In claim 19, “the effluent output” lacks antecedent basis, being inconsistent with recitation in claim 13 of “effluent”. Claim Interpretation In each of claims 1 and 13, “recitations of “discharging…and then adding chitosan to the foamate” are interpreted to mean that chitosan is added one of more of preceding, during and/or after the discharging. Allowable Subject Matter Claims 1-20 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) and Obviousness Double Patenting, set forth in this Office action. Each of independent claims 1 and 13 are deemed to distinguish and be non-obvious over all of the now cited prior art in view of respective recitations of “pretreating wastewater containing organic matters, the pretreating including adding one or more pretreatment chemicals to the wastewater to form a pretreated wastewater mixture; supplying the pretreated wastewater mixture into a foam fractionation system, whereby the pretreated wastewater mixture is separated into a foamate and an effluent within the foam fractionation system, wherein the foamate comprises foams on which at least a portion of the organic matters are adsorbed; in view of further recitation of: adding chitosan to the foamate. The closest prior art is replete with references teaching such wastewater pretreating including adding pretreatment chemicals, followed by supplying a pretreated wastewater mixture into a foam fractionation or similar foam or froth flotation system wherein the mixture is separated into an effluent and a foamate comprises foams on which at least a portion of the organic matters are adsorbed, including prior art teaching adding chitosan, or an equivalent chitin material. Such closest prior art includes the Publication Article of Hossain et al, Eriksson (US 2008/0023407) Man (US 2014/0251920), Eades (US 2005/0161406), patent publication CN 107138289, and Cone et al (US 2014/0014584) which each teach wastewater pretreating including adding pretreatment chemicals, followed by supplying a pretreated wastewater mixture into a foam fractionation or similar foam or froth flotation system wherein the mixture is separated into an effluent and a foamate, with each of Hossain, CN ‘289 and Cone also explicitly teaching addition of chitosan to wastewater either prior to, or during treatment by foam fractionation or foam or froth flotation. However, none of the prior art teaches or suggests such chitin addition to foamate which has been separated from an effluent, as claimed. Thus, claims 2-12 and 14-20 would also be deemed to distinguish and be non-obvious in view of their dependence on allowable claims 1 and 13. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Primary Examiner Joseph Drodge at his direct government formal facsimile phone number telephone number of 571-272-1140. The examiner can normally be reached on Monday-Friday from approximately 8:00 AM to 1:00PM and 2:30 PM to 5:30 PM. Examiner interviews are available via telephone, in-person and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encourage to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner are unsuccessful, the examiner' s supervisor, Benjamin Lebron, of Technology Center Unit 1773, can reached at 571-272-0475. The telephone number, for official, formal communications, for the examining group where this application is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from the Patent Examiner. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https:///www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https:///www.uspto.gov/patents/apply/patents/docx for information about filing in DOCX format. For additional questions contact the Electronic Business Center EBC) at 866-217-9197 (toll free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (in USA or Canada) or 571-272-1000. JWD 10/16/2026 /JOSEPH W DRODGE/ Primary Examiner, Art Unit 1773
Read full office action

Prosecution Timeline

Oct 18, 2024
Application Filed
Oct 20, 2026
Non-Final Rejection mailed — §112, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12782326
METHODS AND SYSTEMS FOR ASSESSING CHROMATOGRAPHIC COLUMN INTEGRITY
2y 10m to grant Granted Nov 03, 2026
Patent 12774223
INTEGRATED SYSTEM OF ACTIVATED CARBON REGENERATION AND WATER TREATMENT
4y 10m to grant Granted Oct 27, 2026
Patent 12773678
SELECTIVE APPROACH TO SEPARATE AND CONCENTRATE RARE EARTH ELEMENTS
3y 5m to grant Granted Oct 27, 2026
Patent 12774427
METHOD FOR SEPARATING AND QUANTIFYING SATURATED AND UNSATURATED DIALKYL KETONES
2y 10m to grant Granted Oct 27, 2026
Patent 12766469
POROUS COMPOSITE
2y 10m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
78%
Grant Probability
99%
With Interview (+37.9%)
2y 7m (~7m remaining)
Median Time to Grant
Low
PTA Risk
Based on 2041 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month